Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of CCH in Cellulite
NCT03675685Phase 1Completed
- Sponsor
- Endo International plc
- Start
- Sep 2018
- Primary completion
- Nov 2018
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of collagenase clostridium histolyticum in cellulite, sponsored by Endo International plc. Primary endpoints: Plasma AUX-I and AUX-II Concentrations at Day 22, Investigator Clinician-Reported Photonumeric Cellulite Severity Scale Rating at Day 22 and 2 more. Started Sep 2018; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
cellulite
Beyond the preview
Go deeper on NCT03675685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03675685.